Christopher Seabrooke Gains 11 Million From Sabvest Stake

South African tycoon Christopher Seabrookes stake in Sabvest surges, adding 11 million to his wealth as the companys shares soar.

Sabvest Capital's 2024 revenue skyrockets to 49.3 million, reversing last year's losses and showcasing strong financial growth.

Sabvest's stock jumps 15, boosting Seabrooke's stake to nearly 86 million, signaling investor confidence and solid market performance.

South African businessman Christopher Seabrooke has seen a notable increase in his wealth, thanks to a sharp rise in the stock price of Sabvest Capital, where he holds a 41.7 percent stake. This surge has boosted the value of his holdings by over 11 million.

As the largest shareholder and CEO of Sabvest, Seabrooke owns 16 million shares in the investment holding company. His stake has recently gained R205.28 million 11.14 million, reflecting growing investor confidence and the companys strong performance in the market. This positive shift comes after a tough period earlier in the year when Seabrooke saw his wealth dip by 6.35 million due to a decline in the companys stock price.

Sabvest Capital , a Sandton-based investment holding company, is involved in various investment activities, including finance advances and managing portfolios of listed debt, equity, and cash. The company also holds significant stakes in unlisted businesses and maintains long-term investments in both listed firms and offshore bond portfolios.

For the financial year ending 2024 , Sabvest achieved a record revenue of R908.82 million 49.3 million, a sharp increase from R5 million 0.27 million in 2023. Net income also bounced back to R899.29 million 48.78 million, compared to a loss of R4.34 million 0.24 million the previous year.

Investors responded positively to these results, driving Sabvest's shares up from R86.21 4.68 on March 14 to R99.04 5.37, pushing its market capitalization over 200 million. As a result, Seabrooke's stake in Sabvest has grown to R1.58 billion 85.97 million, up from R1.38 billion 74.84 million, signaling a significant recovery for the company.